[OutsiderFan]

The most important part of the suggested Iger moves was left out in the above post.

That is when he said they will "permanently" have "less office space." This could mean fewer employees, but it also means more people working from home, and companies now knowing they really don't need to be leasing as much space, to say nothing of businesses going under that once leased, or those that might have, not gonna be leasing ever.

The commercial real estate market is going to be crushed, so naturally the FED is going to buy CRE mortgages now. 

Picking up on the thrust of this thread, the serology testing only matters if we know those who test positive for the antibodies have enough of them to fight off the virus, and if we know immunity lasts.  The issue I see is there seems to be consensus from virologists that immunity isn't likely to last more than 2 years. This has implications for vaccine being viable. And it's not like the flu vaccine completely stops people from getting the flu as is.

Even if 10x more people have been infected than have been reported in confirmed case count (which seems likely), and 5 million Americans have been exposed, that's just 1.5% of the population. So the virus is  going to be new for most people for a long ass time. All these realities make going back to pre-pandemic life fraught with problems that will keep a large percentage of GDP from returning for some time.

Given the scale of issues, I'd put 1/3 of my medical research budget effort into vaccine development, 1/3 into testing and contact tracing, and 1/3 into researching what happens with re-infections and antibodies. 

It's comical to see these Wall Street investment knuckleheads talking about hopeful signs based on curves flattening, when they are only flattening because we have shut down life outside our homes. As soon as we go back to normal, the waves will build again, even if only because the virus is everywhere across the globe.

[OutsiderFan]

The most important part of the suggested Iger moves was left out in the above post.

That is when he said they will "permanently" have "less office space." This could mean fewer employees, but it also means more people working from home, and companies now knowing they really don't need to be leasing as much space, to say nothing of businesses going under that once leased, or those that might have, not gonna be leasing ever.

The commercial real estate market is going to be crushed, so naturally the FED is going to buy CRE mortgages now. 

Picking up on the thrust of this thread, the serology testing only matters if we know those who test positive for the antibodies have enough of them to fight off the virus, and if we know immunity lasts.  The issue I see is there seems to be consensus from virologists that immunity isn't likely to last more than 2 years. This has implications for vaccine being viable. And it's not like the flu vaccine completely stops people from getting the flu as is.

Even if 10x more people have been infected than have been reported in confirmed case count (which seems likely), and 5 million Americans have been exposed, that's just 1.5% of the population. So the virus is  going to be new for most people for a long ass time. All these realities make going back to pre-pandemic life fraught with problems that will keep a large percentage of GDP from returning for some time.

Given the scale of issues, I'd put 1/3 of my medical research budget effort into vaccine development, 1/3 into testing and contact tracing, and 1/3 into researching what happens with re-infections and antibodies. 

It's comical to see these Wall Street investment knuckleheads talking about hopeful signs based on curves flattening, when they are only flattening because we have shut down life outside our homes. As soon as we go back to normal, the waves will build again, even if only because the virus is everywhere across the globe.